In Brief This Week: Caliper; PerkinElmer; Becton Dickinson; iGenix; Intrexon; Genedata, Takeda; EMBL-EBI | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences said that its LabChip Dx instrument has received the CE IVD Mark, making the instrument available for use with clinical patient samples in Europe. The instrument was developed in collaboration with South Korean molecular diagnostics firm Seegene and runs assays developed by Seegene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.